A US congressional commission is escalating its warning that the US could soon be eclipsed by China in biotech, after lawmakers took up some of

The head of a UK government committee has demanded more details on how the country is planning to fund the higher prices it will pay

Thanks to CEPI, Moderna’s H5 bird flu vaccine can start a pivotal trial shelved after funding for the jab was pulled in the US by

The FDA placed a partial hold on Daiichi Sankyo and Merck’s Phase 3 study of a lung cancer drug after the companies paused enrollment for

Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.